Global AI-assisted Drug Design (AIDD) Supply, Demand and Key Producers, 2023-2029
The global AI-assisted Drug Design (AIDD) market size is expected to reach $ 8513.8 million by 2029, rising at a market growth of 29.3% CAGR during the forecast period (2023-2029).
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
This report studies the global AI-assisted Drug Design (AIDD) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI-assisted Drug Design (AIDD), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI-assisted Drug Design (AIDD) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI-assisted Drug Design (AIDD) total market, 2018-2029, (USD Million)
Global AI-assisted Drug Design (AIDD) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: AI-assisted Drug Design (AIDD) total market, key domestic companies and share, (USD Million)
Global AI-assisted Drug Design (AIDD) revenue by player and market share 2018-2023, (USD Million)
Global AI-assisted Drug Design (AIDD) total market by Type, CAGR, 2018-2029, (USD Million)
Global AI-assisted Drug Design (AIDD) total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global AI-assisted Drug Design (AIDD) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI-assisted Drug Design (AIDD) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global AI-assisted Drug Design (AIDD) Market, By Region:
1. How big is the global AI-assisted Drug Design (AIDD) market?
2. What is the demand of the global AI-assisted Drug Design (AIDD) market?
3. What is the year over year growth of the global AI-assisted Drug Design (AIDD) market?
4. What is the total value of the global AI-assisted Drug Design (AIDD) market?
5. Who are the major players in the global AI-assisted Drug Design (AIDD) market?
6. What are the growth factors driving the market demand?
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
This report studies the global AI-assisted Drug Design (AIDD) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI-assisted Drug Design (AIDD), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI-assisted Drug Design (AIDD) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI-assisted Drug Design (AIDD) total market, 2018-2029, (USD Million)
Global AI-assisted Drug Design (AIDD) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: AI-assisted Drug Design (AIDD) total market, key domestic companies and share, (USD Million)
Global AI-assisted Drug Design (AIDD) revenue by player and market share 2018-2023, (USD Million)
Global AI-assisted Drug Design (AIDD) total market by Type, CAGR, 2018-2029, (USD Million)
Global AI-assisted Drug Design (AIDD) total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global AI-assisted Drug Design (AIDD) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI-assisted Drug Design (AIDD) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global AI-assisted Drug Design (AIDD) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Hardware
- Software
- Service
- Early Drug Discovery
- Preclinical Phase
- Clinical Phase
- Regulatory Approval
- IBM
- Exscientia
- Google(Alphabet)
- Microsoft
- Atomwise
- Schrodinger
- Aitia
- Insilico Medicine
- NVIDIA
- XtalPi
- BPGbio
- Owkin
- CytoReason
- Deep Genomics
- Cloud Pharmaceuticals
- BenevolentAI
- Cyclica
- Verge Genomics
- Valo Health
- Envisagenics
- Euretos
- BioAge Labs
- Iktos
- BioSymetrics
- Evaxion Biotech
- Aria Pharmaceuticals
1. How big is the global AI-assisted Drug Design (AIDD) market?
2. What is the demand of the global AI-assisted Drug Design (AIDD) market?
3. What is the year over year growth of the global AI-assisted Drug Design (AIDD) market?
4. What is the total value of the global AI-assisted Drug Design (AIDD) market?
5. Who are the major players in the global AI-assisted Drug Design (AIDD) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI-assisted Drug Design (AIDD) Introduction
1.2 World AI-assisted Drug Design (AIDD) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World AI-assisted Drug Design (AIDD) Total Market by Region (by Headquarter Location)
1.3.1 World AI-assisted Drug Design (AIDD) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.3 China AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.4 Europe AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.5 Japan AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.6 South Korea AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.7 ASEAN AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.8 India AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI-assisted Drug Design (AIDD) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI-assisted Drug Design (AIDD) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.2 World AI-assisted Drug Design (AIDD) Consumption Value by Region
2.2.1 World AI-assisted Drug Design (AIDD) Consumption Value by Region (2018-2023)
2.2.2 World AI-assisted Drug Design (AIDD) Consumption Value Forecast by Region (2024-2029)
2.3 United States AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.4 China AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.5 Europe AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.6 Japan AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.7 South Korea AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.8 ASEAN AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.9 India AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
3 WORLD AI-ASSISTED DRUG DESIGN (AIDD) COMPANIES COMPETITIVE ANALYSIS
3.1 World AI-assisted Drug Design (AIDD) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI-assisted Drug Design (AIDD) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI-assisted Drug Design (AIDD) in 2022
3.2.3 Global Concentration Ratios (CR8) for AI-assisted Drug Design (AIDD) in 2022
3.3 AI-assisted Drug Design (AIDD) Company Evaluation Quadrant
3.4 AI-assisted Drug Design (AIDD) Market: Overall Company Footprint Analysis
3.4.1 AI-assisted Drug Design (AIDD) Market: Region Footprint
3.4.2 AI-assisted Drug Design (AIDD) Market: Company Product Type Footprint
3.4.3 AI-assisted Drug Design (AIDD) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI-assisted Drug Design (AIDD) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI-assisted Drug Design (AIDD) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: AI-assisted Drug Design (AIDD) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: AI-assisted Drug Design (AIDD) Consumption Value Comparison
4.2.1 United States VS China: AI-assisted Drug Design (AIDD) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: AI-assisted Drug Design (AIDD) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based AI-assisted Drug Design (AIDD) Companies and Market Share, 2018-2023
4.3.1 United States Based AI-assisted Drug Design (AIDD) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023)
4.4 China Based Companies AI-assisted Drug Design (AIDD) Revenue and Market Share, 2018-2023
4.4.1 China Based AI-assisted Drug Design (AIDD) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023)
4.5 Rest of World Based AI-assisted Drug Design (AIDD) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based AI-assisted Drug Design (AIDD) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World AI-assisted Drug Design (AIDD) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Service
5.3 Market Segment by Type
5.3.1 World AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023)
5.3.2 World AI-assisted Drug Design (AIDD) Market Size by Type (2024-2029)
5.3.3 World AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World AI-assisted Drug Design (AIDD) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Early Drug Discovery
6.2.2 Preclinical Phase
6.2.3 Clinical Phase
6.2.4 Regulatory Approval
6.2.5 Regulatory Approval
6.3 Market Segment by Application
6.3.1 World AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023)
6.3.2 World AI-assisted Drug Design (AIDD) Market Size by Application (2024-2029)
6.3.3 World AI-assisted Drug Design (AIDD) Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 IBM
7.1.1 IBM Details
7.1.2 IBM Major Business
7.1.3 IBM AI-assisted Drug Design (AIDD) Product and Services
7.1.4 IBM AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 IBM Recent Developments/Updates
7.1.6 IBM Competitive Strengths & Weaknesses
7.2 Exscientia
7.2.1 Exscientia Details
7.2.2 Exscientia Major Business
7.2.3 Exscientia AI-assisted Drug Design (AIDD) Product and Services
7.2.4 Exscientia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Exscientia Recent Developments/Updates
7.2.6 Exscientia Competitive Strengths & Weaknesses
7.3 Google(Alphabet)
7.3.1 Google(Alphabet) Details
7.3.2 Google(Alphabet) Major Business
7.3.3 Google(Alphabet) AI-assisted Drug Design (AIDD) Product and Services
7.3.4 Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Google(Alphabet) Recent Developments/Updates
7.3.6 Google(Alphabet) Competitive Strengths & Weaknesses
7.4 Microsoft
7.4.1 Microsoft Details
7.4.2 Microsoft Major Business
7.4.3 Microsoft AI-assisted Drug Design (AIDD) Product and Services
7.4.4 Microsoft AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Microsoft Recent Developments/Updates
7.4.6 Microsoft Competitive Strengths & Weaknesses
7.5 Atomwise
7.5.1 Atomwise Details
7.5.2 Atomwise Major Business
7.5.3 Atomwise AI-assisted Drug Design (AIDD) Product and Services
7.5.4 Atomwise AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Atomwise Recent Developments/Updates
7.5.6 Atomwise Competitive Strengths & Weaknesses
7.6 Schrodinger
7.6.1 Schrodinger Details
7.6.2 Schrodinger Major Business
7.6.3 Schrodinger AI-assisted Drug Design (AIDD) Product and Services
7.6.4 Schrodinger AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Schrodinger Recent Developments/Updates
7.6.6 Schrodinger Competitive Strengths & Weaknesses
7.7 Aitia
7.7.1 Aitia Details
7.7.2 Aitia Major Business
7.7.3 Aitia AI-assisted Drug Design (AIDD) Product and Services
7.7.4 Aitia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Aitia Recent Developments/Updates
7.7.6 Aitia Competitive Strengths & Weaknesses
7.8 Insilico Medicine
7.8.1 Insilico Medicine Details
7.8.2 Insilico Medicine Major Business
7.8.3 Insilico Medicine AI-assisted Drug Design (AIDD) Product and Services
7.8.4 Insilico Medicine AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Insilico Medicine Recent Developments/Updates
7.8.6 Insilico Medicine Competitive Strengths & Weaknesses
7.9 NVIDIA
7.9.1 NVIDIA Details
7.9.2 NVIDIA Major Business
7.9.3 NVIDIA AI-assisted Drug Design (AIDD) Product and Services
7.9.4 NVIDIA AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 NVIDIA Recent Developments/Updates
7.9.6 NVIDIA Competitive Strengths & Weaknesses
7.10 XtalPi
7.10.1 XtalPi Details
7.10.2 XtalPi Major Business
7.10.3 XtalPi AI-assisted Drug Design (AIDD) Product and Services
7.10.4 XtalPi AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 XtalPi Recent Developments/Updates
7.10.6 XtalPi Competitive Strengths & Weaknesses
7.11 BPGbio
7.11.1 BPGbio Details
7.11.2 BPGbio Major Business
7.11.3 BPGbio AI-assisted Drug Design (AIDD) Product and Services
7.11.4 BPGbio AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 BPGbio Recent Developments/Updates
7.11.6 BPGbio Competitive Strengths & Weaknesses
7.12 Owkin
7.12.1 Owkin Details
7.12.2 Owkin Major Business
7.12.3 Owkin AI-assisted Drug Design (AIDD) Product and Services
7.12.4 Owkin AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Owkin Recent Developments/Updates
7.12.6 Owkin Competitive Strengths & Weaknesses
7.13 CytoReason
7.13.1 CytoReason Details
7.13.2 CytoReason Major Business
7.13.3 CytoReason AI-assisted Drug Design (AIDD) Product and Services
7.13.4 CytoReason AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 CytoReason Recent Developments/Updates
7.13.6 CytoReason Competitive Strengths & Weaknesses
7.14 Deep Genomics
7.14.1 Deep Genomics Details
7.14.2 Deep Genomics Major Business
7.14.3 Deep Genomics AI-assisted Drug Design (AIDD) Product and Services
7.14.4 Deep Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Deep Genomics Recent Developments/Updates
7.14.6 Deep Genomics Competitive Strengths & Weaknesses
7.15 Cloud Pharmaceuticals
7.15.1 Cloud Pharmaceuticals Details
7.15.2 Cloud Pharmaceuticals Major Business
7.15.3 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Services
7.15.4 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Cloud Pharmaceuticals Recent Developments/Updates
7.15.6 Cloud Pharmaceuticals Competitive Strengths & Weaknesses
7.16 BenevolentAI
7.16.1 BenevolentAI Details
7.16.2 BenevolentAI Major Business
7.16.3 BenevolentAI AI-assisted Drug Design (AIDD) Product and Services
7.16.4 BenevolentAI AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 BenevolentAI Recent Developments/Updates
7.16.6 BenevolentAI Competitive Strengths & Weaknesses
7.17 Cyclica
7.17.1 Cyclica Details
7.17.2 Cyclica Major Business
7.17.3 Cyclica AI-assisted Drug Design (AIDD) Product and Services
7.17.4 Cyclica AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Cyclica Recent Developments/Updates
7.17.6 Cyclica Competitive Strengths & Weaknesses
7.18 Verge Genomics
7.18.1 Verge Genomics Details
7.18.2 Verge Genomics Major Business
7.18.3 Verge Genomics AI-assisted Drug Design (AIDD) Product and Services
7.18.4 Verge Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Verge Genomics Recent Developments/Updates
7.18.6 Verge Genomics Competitive Strengths & Weaknesses
7.19 Valo Health
7.19.1 Valo Health Details
7.19.2 Valo Health Major Business
7.19.3 Valo Health AI-assisted Drug Design (AIDD) Product and Services
7.19.4 Valo Health AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Valo Health Recent Developments/Updates
7.19.6 Valo Health Competitive Strengths & Weaknesses
7.20 Envisagenics
7.20.1 Envisagenics Details
7.20.2 Envisagenics Major Business
7.20.3 Envisagenics AI-assisted Drug Design (AIDD) Product and Services
7.20.4 Envisagenics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Envisagenics Recent Developments/Updates
7.20.6 Envisagenics Competitive Strengths & Weaknesses
7.21 Euretos
7.21.1 Euretos Details
7.21.2 Euretos Major Business
7.21.3 Euretos AI-assisted Drug Design (AIDD) Product and Services
7.21.4 Euretos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Euretos Recent Developments/Updates
7.21.6 Euretos Competitive Strengths & Weaknesses
7.22 BioAge Labs
7.22.1 BioAge Labs Details
7.22.2 BioAge Labs Major Business
7.22.3 BioAge Labs AI-assisted Drug Design (AIDD) Product and Services
7.22.4 BioAge Labs AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 BioAge Labs Recent Developments/Updates
7.22.6 BioAge Labs Competitive Strengths & Weaknesses
7.23 Iktos
7.23.1 Iktos Details
7.23.2 Iktos Major Business
7.23.3 Iktos AI-assisted Drug Design (AIDD) Product and Services
7.23.4 Iktos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Iktos Recent Developments/Updates
7.23.6 Iktos Competitive Strengths & Weaknesses
7.24 BioSymetrics
7.24.1 BioSymetrics Details
7.24.2 BioSymetrics Major Business
7.24.3 BioSymetrics AI-assisted Drug Design (AIDD) Product and Services
7.24.4 BioSymetrics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 BioSymetrics Recent Developments/Updates
7.24.6 BioSymetrics Competitive Strengths & Weaknesses
7.25 Evaxion Biotech
7.25.1 Evaxion Biotech Details
7.25.2 Evaxion Biotech Major Business
7.25.3 Evaxion Biotech AI-assisted Drug Design (AIDD) Product and Services
7.25.4 Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Evaxion Biotech Recent Developments/Updates
7.25.6 Evaxion Biotech Competitive Strengths & Weaknesses
7.26 Aria Pharmaceuticals
7.26.1 Aria Pharmaceuticals Details
7.26.2 Aria Pharmaceuticals Major Business
7.26.3 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Services
7.26.4 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Aria Pharmaceuticals Recent Developments/Updates
7.26.6 Aria Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 AI-assisted Drug Design (AIDD) Industry Chain
8.2 AI-assisted Drug Design (AIDD) Upstream Analysis
8.3 AI-assisted Drug Design (AIDD) Midstream Analysis
8.4 AI-assisted Drug Design (AIDD) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 AI-assisted Drug Design (AIDD) Introduction
1.2 World AI-assisted Drug Design (AIDD) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World AI-assisted Drug Design (AIDD) Total Market by Region (by Headquarter Location)
1.3.1 World AI-assisted Drug Design (AIDD) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.3 China AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.4 Europe AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.5 Japan AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.6 South Korea AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.7 ASEAN AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.3.8 India AI-assisted Drug Design (AIDD) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI-assisted Drug Design (AIDD) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI-assisted Drug Design (AIDD) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.2 World AI-assisted Drug Design (AIDD) Consumption Value by Region
2.2.1 World AI-assisted Drug Design (AIDD) Consumption Value by Region (2018-2023)
2.2.2 World AI-assisted Drug Design (AIDD) Consumption Value Forecast by Region (2024-2029)
2.3 United States AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.4 China AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.5 Europe AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.6 Japan AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.7 South Korea AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.8 ASEAN AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
2.9 India AI-assisted Drug Design (AIDD) Consumption Value (2018-2029)
3 WORLD AI-ASSISTED DRUG DESIGN (AIDD) COMPANIES COMPETITIVE ANALYSIS
3.1 World AI-assisted Drug Design (AIDD) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI-assisted Drug Design (AIDD) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI-assisted Drug Design (AIDD) in 2022
3.2.3 Global Concentration Ratios (CR8) for AI-assisted Drug Design (AIDD) in 2022
3.3 AI-assisted Drug Design (AIDD) Company Evaluation Quadrant
3.4 AI-assisted Drug Design (AIDD) Market: Overall Company Footprint Analysis
3.4.1 AI-assisted Drug Design (AIDD) Market: Region Footprint
3.4.2 AI-assisted Drug Design (AIDD) Market: Company Product Type Footprint
3.4.3 AI-assisted Drug Design (AIDD) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI-assisted Drug Design (AIDD) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI-assisted Drug Design (AIDD) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: AI-assisted Drug Design (AIDD) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: AI-assisted Drug Design (AIDD) Consumption Value Comparison
4.2.1 United States VS China: AI-assisted Drug Design (AIDD) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: AI-assisted Drug Design (AIDD) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based AI-assisted Drug Design (AIDD) Companies and Market Share, 2018-2023
4.3.1 United States Based AI-assisted Drug Design (AIDD) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023)
4.4 China Based Companies AI-assisted Drug Design (AIDD) Revenue and Market Share, 2018-2023
4.4.1 China Based AI-assisted Drug Design (AIDD) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023)
4.5 Rest of World Based AI-assisted Drug Design (AIDD) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based AI-assisted Drug Design (AIDD) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World AI-assisted Drug Design (AIDD) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Service
5.3 Market Segment by Type
5.3.1 World AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023)
5.3.2 World AI-assisted Drug Design (AIDD) Market Size by Type (2024-2029)
5.3.3 World AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World AI-assisted Drug Design (AIDD) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Early Drug Discovery
6.2.2 Preclinical Phase
6.2.3 Clinical Phase
6.2.4 Regulatory Approval
6.2.5 Regulatory Approval
6.3 Market Segment by Application
6.3.1 World AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023)
6.3.2 World AI-assisted Drug Design (AIDD) Market Size by Application (2024-2029)
6.3.3 World AI-assisted Drug Design (AIDD) Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 IBM
7.1.1 IBM Details
7.1.2 IBM Major Business
7.1.3 IBM AI-assisted Drug Design (AIDD) Product and Services
7.1.4 IBM AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 IBM Recent Developments/Updates
7.1.6 IBM Competitive Strengths & Weaknesses
7.2 Exscientia
7.2.1 Exscientia Details
7.2.2 Exscientia Major Business
7.2.3 Exscientia AI-assisted Drug Design (AIDD) Product and Services
7.2.4 Exscientia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Exscientia Recent Developments/Updates
7.2.6 Exscientia Competitive Strengths & Weaknesses
7.3 Google(Alphabet)
7.3.1 Google(Alphabet) Details
7.3.2 Google(Alphabet) Major Business
7.3.3 Google(Alphabet) AI-assisted Drug Design (AIDD) Product and Services
7.3.4 Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Google(Alphabet) Recent Developments/Updates
7.3.6 Google(Alphabet) Competitive Strengths & Weaknesses
7.4 Microsoft
7.4.1 Microsoft Details
7.4.2 Microsoft Major Business
7.4.3 Microsoft AI-assisted Drug Design (AIDD) Product and Services
7.4.4 Microsoft AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Microsoft Recent Developments/Updates
7.4.6 Microsoft Competitive Strengths & Weaknesses
7.5 Atomwise
7.5.1 Atomwise Details
7.5.2 Atomwise Major Business
7.5.3 Atomwise AI-assisted Drug Design (AIDD) Product and Services
7.5.4 Atomwise AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Atomwise Recent Developments/Updates
7.5.6 Atomwise Competitive Strengths & Weaknesses
7.6 Schrodinger
7.6.1 Schrodinger Details
7.6.2 Schrodinger Major Business
7.6.3 Schrodinger AI-assisted Drug Design (AIDD) Product and Services
7.6.4 Schrodinger AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Schrodinger Recent Developments/Updates
7.6.6 Schrodinger Competitive Strengths & Weaknesses
7.7 Aitia
7.7.1 Aitia Details
7.7.2 Aitia Major Business
7.7.3 Aitia AI-assisted Drug Design (AIDD) Product and Services
7.7.4 Aitia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Aitia Recent Developments/Updates
7.7.6 Aitia Competitive Strengths & Weaknesses
7.8 Insilico Medicine
7.8.1 Insilico Medicine Details
7.8.2 Insilico Medicine Major Business
7.8.3 Insilico Medicine AI-assisted Drug Design (AIDD) Product and Services
7.8.4 Insilico Medicine AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Insilico Medicine Recent Developments/Updates
7.8.6 Insilico Medicine Competitive Strengths & Weaknesses
7.9 NVIDIA
7.9.1 NVIDIA Details
7.9.2 NVIDIA Major Business
7.9.3 NVIDIA AI-assisted Drug Design (AIDD) Product and Services
7.9.4 NVIDIA AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 NVIDIA Recent Developments/Updates
7.9.6 NVIDIA Competitive Strengths & Weaknesses
7.10 XtalPi
7.10.1 XtalPi Details
7.10.2 XtalPi Major Business
7.10.3 XtalPi AI-assisted Drug Design (AIDD) Product and Services
7.10.4 XtalPi AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 XtalPi Recent Developments/Updates
7.10.6 XtalPi Competitive Strengths & Weaknesses
7.11 BPGbio
7.11.1 BPGbio Details
7.11.2 BPGbio Major Business
7.11.3 BPGbio AI-assisted Drug Design (AIDD) Product and Services
7.11.4 BPGbio AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 BPGbio Recent Developments/Updates
7.11.6 BPGbio Competitive Strengths & Weaknesses
7.12 Owkin
7.12.1 Owkin Details
7.12.2 Owkin Major Business
7.12.3 Owkin AI-assisted Drug Design (AIDD) Product and Services
7.12.4 Owkin AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Owkin Recent Developments/Updates
7.12.6 Owkin Competitive Strengths & Weaknesses
7.13 CytoReason
7.13.1 CytoReason Details
7.13.2 CytoReason Major Business
7.13.3 CytoReason AI-assisted Drug Design (AIDD) Product and Services
7.13.4 CytoReason AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 CytoReason Recent Developments/Updates
7.13.6 CytoReason Competitive Strengths & Weaknesses
7.14 Deep Genomics
7.14.1 Deep Genomics Details
7.14.2 Deep Genomics Major Business
7.14.3 Deep Genomics AI-assisted Drug Design (AIDD) Product and Services
7.14.4 Deep Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Deep Genomics Recent Developments/Updates
7.14.6 Deep Genomics Competitive Strengths & Weaknesses
7.15 Cloud Pharmaceuticals
7.15.1 Cloud Pharmaceuticals Details
7.15.2 Cloud Pharmaceuticals Major Business
7.15.3 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Services
7.15.4 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Cloud Pharmaceuticals Recent Developments/Updates
7.15.6 Cloud Pharmaceuticals Competitive Strengths & Weaknesses
7.16 BenevolentAI
7.16.1 BenevolentAI Details
7.16.2 BenevolentAI Major Business
7.16.3 BenevolentAI AI-assisted Drug Design (AIDD) Product and Services
7.16.4 BenevolentAI AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 BenevolentAI Recent Developments/Updates
7.16.6 BenevolentAI Competitive Strengths & Weaknesses
7.17 Cyclica
7.17.1 Cyclica Details
7.17.2 Cyclica Major Business
7.17.3 Cyclica AI-assisted Drug Design (AIDD) Product and Services
7.17.4 Cyclica AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Cyclica Recent Developments/Updates
7.17.6 Cyclica Competitive Strengths & Weaknesses
7.18 Verge Genomics
7.18.1 Verge Genomics Details
7.18.2 Verge Genomics Major Business
7.18.3 Verge Genomics AI-assisted Drug Design (AIDD) Product and Services
7.18.4 Verge Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Verge Genomics Recent Developments/Updates
7.18.6 Verge Genomics Competitive Strengths & Weaknesses
7.19 Valo Health
7.19.1 Valo Health Details
7.19.2 Valo Health Major Business
7.19.3 Valo Health AI-assisted Drug Design (AIDD) Product and Services
7.19.4 Valo Health AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Valo Health Recent Developments/Updates
7.19.6 Valo Health Competitive Strengths & Weaknesses
7.20 Envisagenics
7.20.1 Envisagenics Details
7.20.2 Envisagenics Major Business
7.20.3 Envisagenics AI-assisted Drug Design (AIDD) Product and Services
7.20.4 Envisagenics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Envisagenics Recent Developments/Updates
7.20.6 Envisagenics Competitive Strengths & Weaknesses
7.21 Euretos
7.21.1 Euretos Details
7.21.2 Euretos Major Business
7.21.3 Euretos AI-assisted Drug Design (AIDD) Product and Services
7.21.4 Euretos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Euretos Recent Developments/Updates
7.21.6 Euretos Competitive Strengths & Weaknesses
7.22 BioAge Labs
7.22.1 BioAge Labs Details
7.22.2 BioAge Labs Major Business
7.22.3 BioAge Labs AI-assisted Drug Design (AIDD) Product and Services
7.22.4 BioAge Labs AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 BioAge Labs Recent Developments/Updates
7.22.6 BioAge Labs Competitive Strengths & Weaknesses
7.23 Iktos
7.23.1 Iktos Details
7.23.2 Iktos Major Business
7.23.3 Iktos AI-assisted Drug Design (AIDD) Product and Services
7.23.4 Iktos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Iktos Recent Developments/Updates
7.23.6 Iktos Competitive Strengths & Weaknesses
7.24 BioSymetrics
7.24.1 BioSymetrics Details
7.24.2 BioSymetrics Major Business
7.24.3 BioSymetrics AI-assisted Drug Design (AIDD) Product and Services
7.24.4 BioSymetrics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 BioSymetrics Recent Developments/Updates
7.24.6 BioSymetrics Competitive Strengths & Weaknesses
7.25 Evaxion Biotech
7.25.1 Evaxion Biotech Details
7.25.2 Evaxion Biotech Major Business
7.25.3 Evaxion Biotech AI-assisted Drug Design (AIDD) Product and Services
7.25.4 Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Evaxion Biotech Recent Developments/Updates
7.25.6 Evaxion Biotech Competitive Strengths & Weaknesses
7.26 Aria Pharmaceuticals
7.26.1 Aria Pharmaceuticals Details
7.26.2 Aria Pharmaceuticals Major Business
7.26.3 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Services
7.26.4 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Aria Pharmaceuticals Recent Developments/Updates
7.26.6 Aria Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 AI-assisted Drug Design (AIDD) Industry Chain
8.2 AI-assisted Drug Design (AIDD) Upstream Analysis
8.3 AI-assisted Drug Design (AIDD) Midstream Analysis
8.4 AI-assisted Drug Design (AIDD) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World AI-assisted Drug Design (AIDD) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World AI-assisted Drug Design (AIDD) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World AI-assisted Drug Design (AIDD) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World AI-assisted Drug Design (AIDD) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World AI-assisted Drug Design (AIDD) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI-assisted Drug Design (AIDD) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World AI-assisted Drug Design (AIDD) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World AI-assisted Drug Design (AIDD) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World AI-assisted Drug Design (AIDD) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key AI-assisted Drug Design (AIDD) Players in 2022
Table 12. World AI-assisted Drug Design (AIDD) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global AI-assisted Drug Design (AIDD) Company Evaluation Quadrant
Table 14. Head Office of Key AI-assisted Drug Design (AIDD) Player
Table 15. AI-assisted Drug Design (AIDD) Market: Company Product Type Footprint
Table 16. AI-assisted Drug Design (AIDD) Market: Company Product Application Footprint
Table 17. AI-assisted Drug Design (AIDD) Mergers & Acquisitions Activity
Table 18. United States VS China AI-assisted Drug Design (AIDD) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China AI-assisted Drug Design (AIDD) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based AI-assisted Drug Design (AIDD) Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies AI-assisted Drug Design (AIDD) Revenue Market Share (2018-2023)
Table 23. China Based AI-assisted Drug Design (AIDD) Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies AI-assisted Drug Design (AIDD) Revenue Market Share (2018-2023)
Table 26. Rest of World Based AI-assisted Drug Design (AIDD) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies AI-assisted Drug Design (AIDD) Revenue Market Share (2018-2023)
Table 29. World AI-assisted Drug Design (AIDD) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & (USD Million)
Table 31. World AI-assisted Drug Design (AIDD) Market Size by Type (2024-2029) & (USD Million)
Table 32. World AI-assisted Drug Design (AIDD) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & (USD Million)
Table 34. World AI-assisted Drug Design (AIDD) Market Size by Application (2024-2029) & (USD Million)
Table 35. IBM Basic Information, Area Served and Competitors
Table 36. IBM Major Business
Table 37. IBM AI-assisted Drug Design (AIDD) Product and Services
Table 38. IBM AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. IBM Recent Developments/Updates
Table 40. IBM Competitive Strengths & Weaknesses
Table 41. Exscientia Basic Information, Area Served and Competitors
Table 42. Exscientia Major Business
Table 43. Exscientia AI-assisted Drug Design (AIDD) Product and Services
Table 44. Exscientia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Exscientia Recent Developments/Updates
Table 46. Exscientia Competitive Strengths & Weaknesses
Table 47. Google(Alphabet) Basic Information, Area Served and Competitors
Table 48. Google(Alphabet) Major Business
Table 49. Google(Alphabet) AI-assisted Drug Design (AIDD) Product and Services
Table 50. Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Google(Alphabet) Recent Developments/Updates
Table 52. Google(Alphabet) Competitive Strengths & Weaknesses
Table 53. Microsoft Basic Information, Area Served and Competitors
Table 54. Microsoft Major Business
Table 55. Microsoft AI-assisted Drug Design (AIDD) Product and Services
Table 56. Microsoft AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Microsoft Recent Developments/Updates
Table 58. Microsoft Competitive Strengths & Weaknesses
Table 59. Atomwise Basic Information, Area Served and Competitors
Table 60. Atomwise Major Business
Table 61. Atomwise AI-assisted Drug Design (AIDD) Product and Services
Table 62. Atomwise AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Atomwise Recent Developments/Updates
Table 64. Atomwise Competitive Strengths & Weaknesses
Table 65. Schrodinger Basic Information, Area Served and Competitors
Table 66. Schrodinger Major Business
Table 67. Schrodinger AI-assisted Drug Design (AIDD) Product and Services
Table 68. Schrodinger AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Schrodinger Recent Developments/Updates
Table 70. Schrodinger Competitive Strengths & Weaknesses
Table 71. Aitia Basic Information, Area Served and Competitors
Table 72. Aitia Major Business
Table 73. Aitia AI-assisted Drug Design (AIDD) Product and Services
Table 74. Aitia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Aitia Recent Developments/Updates
Table 76. Aitia Competitive Strengths & Weaknesses
Table 77. Insilico Medicine Basic Information, Area Served and Competitors
Table 78. Insilico Medicine Major Business
Table 79. Insilico Medicine AI-assisted Drug Design (AIDD) Product and Services
Table 80. Insilico Medicine AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Insilico Medicine Recent Developments/Updates
Table 82. Insilico Medicine Competitive Strengths & Weaknesses
Table 83. NVIDIA Basic Information, Area Served and Competitors
Table 84. NVIDIA Major Business
Table 85. NVIDIA AI-assisted Drug Design (AIDD) Product and Services
Table 86. NVIDIA AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. NVIDIA Recent Developments/Updates
Table 88. NVIDIA Competitive Strengths & Weaknesses
Table 89. XtalPi Basic Information, Area Served and Competitors
Table 90. XtalPi Major Business
Table 91. XtalPi AI-assisted Drug Design (AIDD) Product and Services
Table 92. XtalPi AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. XtalPi Recent Developments/Updates
Table 94. XtalPi Competitive Strengths & Weaknesses
Table 95. BPGbio Basic Information, Area Served and Competitors
Table 96. BPGbio Major Business
Table 97. BPGbio AI-assisted Drug Design (AIDD) Product and Services
Table 98. BPGbio AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. BPGbio Recent Developments/Updates
Table 100. BPGbio Competitive Strengths & Weaknesses
Table 101. Owkin Basic Information, Area Served and Competitors
Table 102. Owkin Major Business
Table 103. Owkin AI-assisted Drug Design (AIDD) Product and Services
Table 104. Owkin AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Owkin Recent Developments/Updates
Table 106. Owkin Competitive Strengths & Weaknesses
Table 107. CytoReason Basic Information, Area Served and Competitors
Table 108. CytoReason Major Business
Table 109. CytoReason AI-assisted Drug Design (AIDD) Product and Services
Table 110. CytoReason AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. CytoReason Recent Developments/Updates
Table 112. CytoReason Competitive Strengths & Weaknesses
Table 113. Deep Genomics Basic Information, Area Served and Competitors
Table 114. Deep Genomics Major Business
Table 115. Deep Genomics AI-assisted Drug Design (AIDD) Product and Services
Table 116. Deep Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Deep Genomics Recent Developments/Updates
Table 118. Deep Genomics Competitive Strengths & Weaknesses
Table 119. Cloud Pharmaceuticals Basic Information, Area Served and Competitors
Table 120. Cloud Pharmaceuticals Major Business
Table 121. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Services
Table 122. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Cloud Pharmaceuticals Recent Developments/Updates
Table 124. Cloud Pharmaceuticals Competitive Strengths & Weaknesses
Table 125. BenevolentAI Basic Information, Area Served and Competitors
Table 126. BenevolentAI Major Business
Table 127. BenevolentAI AI-assisted Drug Design (AIDD) Product and Services
Table 128. BenevolentAI AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. BenevolentAI Recent Developments/Updates
Table 130. BenevolentAI Competitive Strengths & Weaknesses
Table 131. Cyclica Basic Information, Area Served and Competitors
Table 132. Cyclica Major Business
Table 133. Cyclica AI-assisted Drug Design (AIDD) Product and Services
Table 134. Cyclica AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Cyclica Recent Developments/Updates
Table 136. Cyclica Competitive Strengths & Weaknesses
Table 137. Verge Genomics Basic Information, Area Served and Competitors
Table 138. Verge Genomics Major Business
Table 139. Verge Genomics AI-assisted Drug Design (AIDD) Product and Services
Table 140. Verge Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Verge Genomics Recent Developments/Updates
Table 142. Verge Genomics Competitive Strengths & Weaknesses
Table 143. Valo Health Basic Information, Area Served and Competitors
Table 144. Valo Health Major Business
Table 145. Valo Health AI-assisted Drug Design (AIDD) Product and Services
Table 146. Valo Health AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Valo Health Recent Developments/Updates
Table 148. Valo Health Competitive Strengths & Weaknesses
Table 149. Envisagenics Basic Information, Area Served and Competitors
Table 150. Envisagenics Major Business
Table 151. Envisagenics AI-assisted Drug Design (AIDD) Product and Services
Table 152. Envisagenics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Envisagenics Recent Developments/Updates
Table 154. Envisagenics Competitive Strengths & Weaknesses
Table 155. Euretos Basic Information, Area Served and Competitors
Table 156. Euretos Major Business
Table 157. Euretos AI-assisted Drug Design (AIDD) Product and Services
Table 158. Euretos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Euretos Recent Developments/Updates
Table 160. Euretos Competitive Strengths & Weaknesses
Table 161. BioAge Labs Basic Information, Area Served and Competitors
Table 162. BioAge Labs Major Business
Table 163. BioAge Labs AI-assisted Drug Design (AIDD) Product and Services
Table 164. BioAge Labs AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. BioAge Labs Recent Developments/Updates
Table 166. BioAge Labs Competitive Strengths & Weaknesses
Table 167. Iktos Basic Information, Area Served and Competitors
Table 168. Iktos Major Business
Table 169. Iktos AI-assisted Drug Design (AIDD) Product and Services
Table 170. Iktos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Iktos Recent Developments/Updates
Table 172. Iktos Competitive Strengths & Weaknesses
Table 173. BioSymetrics Basic Information, Area Served and Competitors
Table 174. BioSymetrics Major Business
Table 175. BioSymetrics AI-assisted Drug Design (AIDD) Product and Services
Table 176. BioSymetrics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. BioSymetrics Recent Developments/Updates
Table 178. BioSymetrics Competitive Strengths & Weaknesses
Table 179. Evaxion Biotech Basic Information, Area Served and Competitors
Table 180. Evaxion Biotech Major Business
Table 181. Evaxion Biotech AI-assisted Drug Design (AIDD) Product and Services
Table 182. Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. Evaxion Biotech Recent Developments/Updates
Table 184. Aria Pharmaceuticals Basic Information, Area Served and Competitors
Table 185. Aria Pharmaceuticals Major Business
Table 186. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Services
Table 187. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 188. Global Key Players of AI-assisted Drug Design (AIDD) Upstream (Raw Materials)
Table 189. AI-assisted Drug Design (AIDD) Typical Customers
Table 1. World AI-assisted Drug Design (AIDD) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World AI-assisted Drug Design (AIDD) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World AI-assisted Drug Design (AIDD) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World AI-assisted Drug Design (AIDD) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World AI-assisted Drug Design (AIDD) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI-assisted Drug Design (AIDD) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World AI-assisted Drug Design (AIDD) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World AI-assisted Drug Design (AIDD) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World AI-assisted Drug Design (AIDD) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key AI-assisted Drug Design (AIDD) Players in 2022
Table 12. World AI-assisted Drug Design (AIDD) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global AI-assisted Drug Design (AIDD) Company Evaluation Quadrant
Table 14. Head Office of Key AI-assisted Drug Design (AIDD) Player
Table 15. AI-assisted Drug Design (AIDD) Market: Company Product Type Footprint
Table 16. AI-assisted Drug Design (AIDD) Market: Company Product Application Footprint
Table 17. AI-assisted Drug Design (AIDD) Mergers & Acquisitions Activity
Table 18. United States VS China AI-assisted Drug Design (AIDD) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China AI-assisted Drug Design (AIDD) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based AI-assisted Drug Design (AIDD) Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies AI-assisted Drug Design (AIDD) Revenue Market Share (2018-2023)
Table 23. China Based AI-assisted Drug Design (AIDD) Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies AI-assisted Drug Design (AIDD) Revenue Market Share (2018-2023)
Table 26. Rest of World Based AI-assisted Drug Design (AIDD) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI-assisted Drug Design (AIDD) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies AI-assisted Drug Design (AIDD) Revenue Market Share (2018-2023)
Table 29. World AI-assisted Drug Design (AIDD) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & (USD Million)
Table 31. World AI-assisted Drug Design (AIDD) Market Size by Type (2024-2029) & (USD Million)
Table 32. World AI-assisted Drug Design (AIDD) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & (USD Million)
Table 34. World AI-assisted Drug Design (AIDD) Market Size by Application (2024-2029) & (USD Million)
Table 35. IBM Basic Information, Area Served and Competitors
Table 36. IBM Major Business
Table 37. IBM AI-assisted Drug Design (AIDD) Product and Services
Table 38. IBM AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. IBM Recent Developments/Updates
Table 40. IBM Competitive Strengths & Weaknesses
Table 41. Exscientia Basic Information, Area Served and Competitors
Table 42. Exscientia Major Business
Table 43. Exscientia AI-assisted Drug Design (AIDD) Product and Services
Table 44. Exscientia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Exscientia Recent Developments/Updates
Table 46. Exscientia Competitive Strengths & Weaknesses
Table 47. Google(Alphabet) Basic Information, Area Served and Competitors
Table 48. Google(Alphabet) Major Business
Table 49. Google(Alphabet) AI-assisted Drug Design (AIDD) Product and Services
Table 50. Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Google(Alphabet) Recent Developments/Updates
Table 52. Google(Alphabet) Competitive Strengths & Weaknesses
Table 53. Microsoft Basic Information, Area Served and Competitors
Table 54. Microsoft Major Business
Table 55. Microsoft AI-assisted Drug Design (AIDD) Product and Services
Table 56. Microsoft AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Microsoft Recent Developments/Updates
Table 58. Microsoft Competitive Strengths & Weaknesses
Table 59. Atomwise Basic Information, Area Served and Competitors
Table 60. Atomwise Major Business
Table 61. Atomwise AI-assisted Drug Design (AIDD) Product and Services
Table 62. Atomwise AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Atomwise Recent Developments/Updates
Table 64. Atomwise Competitive Strengths & Weaknesses
Table 65. Schrodinger Basic Information, Area Served and Competitors
Table 66. Schrodinger Major Business
Table 67. Schrodinger AI-assisted Drug Design (AIDD) Product and Services
Table 68. Schrodinger AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Schrodinger Recent Developments/Updates
Table 70. Schrodinger Competitive Strengths & Weaknesses
Table 71. Aitia Basic Information, Area Served and Competitors
Table 72. Aitia Major Business
Table 73. Aitia AI-assisted Drug Design (AIDD) Product and Services
Table 74. Aitia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Aitia Recent Developments/Updates
Table 76. Aitia Competitive Strengths & Weaknesses
Table 77. Insilico Medicine Basic Information, Area Served and Competitors
Table 78. Insilico Medicine Major Business
Table 79. Insilico Medicine AI-assisted Drug Design (AIDD) Product and Services
Table 80. Insilico Medicine AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Insilico Medicine Recent Developments/Updates
Table 82. Insilico Medicine Competitive Strengths & Weaknesses
Table 83. NVIDIA Basic Information, Area Served and Competitors
Table 84. NVIDIA Major Business
Table 85. NVIDIA AI-assisted Drug Design (AIDD) Product and Services
Table 86. NVIDIA AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. NVIDIA Recent Developments/Updates
Table 88. NVIDIA Competitive Strengths & Weaknesses
Table 89. XtalPi Basic Information, Area Served and Competitors
Table 90. XtalPi Major Business
Table 91. XtalPi AI-assisted Drug Design (AIDD) Product and Services
Table 92. XtalPi AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. XtalPi Recent Developments/Updates
Table 94. XtalPi Competitive Strengths & Weaknesses
Table 95. BPGbio Basic Information, Area Served and Competitors
Table 96. BPGbio Major Business
Table 97. BPGbio AI-assisted Drug Design (AIDD) Product and Services
Table 98. BPGbio AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. BPGbio Recent Developments/Updates
Table 100. BPGbio Competitive Strengths & Weaknesses
Table 101. Owkin Basic Information, Area Served and Competitors
Table 102. Owkin Major Business
Table 103. Owkin AI-assisted Drug Design (AIDD) Product and Services
Table 104. Owkin AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Owkin Recent Developments/Updates
Table 106. Owkin Competitive Strengths & Weaknesses
Table 107. CytoReason Basic Information, Area Served and Competitors
Table 108. CytoReason Major Business
Table 109. CytoReason AI-assisted Drug Design (AIDD) Product and Services
Table 110. CytoReason AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. CytoReason Recent Developments/Updates
Table 112. CytoReason Competitive Strengths & Weaknesses
Table 113. Deep Genomics Basic Information, Area Served and Competitors
Table 114. Deep Genomics Major Business
Table 115. Deep Genomics AI-assisted Drug Design (AIDD) Product and Services
Table 116. Deep Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Deep Genomics Recent Developments/Updates
Table 118. Deep Genomics Competitive Strengths & Weaknesses
Table 119. Cloud Pharmaceuticals Basic Information, Area Served and Competitors
Table 120. Cloud Pharmaceuticals Major Business
Table 121. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Services
Table 122. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Cloud Pharmaceuticals Recent Developments/Updates
Table 124. Cloud Pharmaceuticals Competitive Strengths & Weaknesses
Table 125. BenevolentAI Basic Information, Area Served and Competitors
Table 126. BenevolentAI Major Business
Table 127. BenevolentAI AI-assisted Drug Design (AIDD) Product and Services
Table 128. BenevolentAI AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. BenevolentAI Recent Developments/Updates
Table 130. BenevolentAI Competitive Strengths & Weaknesses
Table 131. Cyclica Basic Information, Area Served and Competitors
Table 132. Cyclica Major Business
Table 133. Cyclica AI-assisted Drug Design (AIDD) Product and Services
Table 134. Cyclica AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Cyclica Recent Developments/Updates
Table 136. Cyclica Competitive Strengths & Weaknesses
Table 137. Verge Genomics Basic Information, Area Served and Competitors
Table 138. Verge Genomics Major Business
Table 139. Verge Genomics AI-assisted Drug Design (AIDD) Product and Services
Table 140. Verge Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Verge Genomics Recent Developments/Updates
Table 142. Verge Genomics Competitive Strengths & Weaknesses
Table 143. Valo Health Basic Information, Area Served and Competitors
Table 144. Valo Health Major Business
Table 145. Valo Health AI-assisted Drug Design (AIDD) Product and Services
Table 146. Valo Health AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Valo Health Recent Developments/Updates
Table 148. Valo Health Competitive Strengths & Weaknesses
Table 149. Envisagenics Basic Information, Area Served and Competitors
Table 150. Envisagenics Major Business
Table 151. Envisagenics AI-assisted Drug Design (AIDD) Product and Services
Table 152. Envisagenics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Envisagenics Recent Developments/Updates
Table 154. Envisagenics Competitive Strengths & Weaknesses
Table 155. Euretos Basic Information, Area Served and Competitors
Table 156. Euretos Major Business
Table 157. Euretos AI-assisted Drug Design (AIDD) Product and Services
Table 158. Euretos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Euretos Recent Developments/Updates
Table 160. Euretos Competitive Strengths & Weaknesses
Table 161. BioAge Labs Basic Information, Area Served and Competitors
Table 162. BioAge Labs Major Business
Table 163. BioAge Labs AI-assisted Drug Design (AIDD) Product and Services
Table 164. BioAge Labs AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. BioAge Labs Recent Developments/Updates
Table 166. BioAge Labs Competitive Strengths & Weaknesses
Table 167. Iktos Basic Information, Area Served and Competitors
Table 168. Iktos Major Business
Table 169. Iktos AI-assisted Drug Design (AIDD) Product and Services
Table 170. Iktos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Iktos Recent Developments/Updates
Table 172. Iktos Competitive Strengths & Weaknesses
Table 173. BioSymetrics Basic Information, Area Served and Competitors
Table 174. BioSymetrics Major Business
Table 175. BioSymetrics AI-assisted Drug Design (AIDD) Product and Services
Table 176. BioSymetrics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. BioSymetrics Recent Developments/Updates
Table 178. BioSymetrics Competitive Strengths & Weaknesses
Table 179. Evaxion Biotech Basic Information, Area Served and Competitors
Table 180. Evaxion Biotech Major Business
Table 181. Evaxion Biotech AI-assisted Drug Design (AIDD) Product and Services
Table 182. Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. Evaxion Biotech Recent Developments/Updates
Table 184. Aria Pharmaceuticals Basic Information, Area Served and Competitors
Table 185. Aria Pharmaceuticals Major Business
Table 186. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Services
Table 187. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 188. Global Key Players of AI-assisted Drug Design (AIDD) Upstream (Raw Materials)
Table 189. AI-assisted Drug Design (AIDD) Typical Customers
LIST OF FIGURES
Figure 1. AI-assisted Drug Design (AIDD) Picture
Figure 2. World AI-assisted Drug Design (AIDD) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AI-assisted Drug Design (AIDD) Total Market Size (2018-2029) & (USD Million)
Figure 4. World AI-assisted Drug Design (AIDD) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World AI-assisted Drug Design (AIDD) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 13. AI-assisted Drug Design (AIDD) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 16. World AI-assisted Drug Design (AIDD) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 18. China AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 23. India AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of AI-assisted Drug Design (AIDD) by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI-assisted Drug Design (AIDD) Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI-assisted Drug Design (AIDD) Markets in 2022
Figure 27. United States VS China: AI-assisted Drug Design (AIDD) Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AI-assisted Drug Design (AIDD) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World AI-assisted Drug Design (AIDD) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World AI-assisted Drug Design (AIDD) Market Size Market Share by Type in 2022
Figure 31. Hardware
Figure 32. Software
Figure 33. Service
Figure 34. World AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2029)
Figure 35. World AI-assisted Drug Design (AIDD) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World AI-assisted Drug Design (AIDD) Market Size Market Share by Application in 2022
Figure 37. Early Drug Discovery
Figure 38. Preclinical Phase
Figure 39. Clinical Phase
Figure 40. Regulatory Approval
Figure 41. AI-assisted Drug Design (AIDD) Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. AI-assisted Drug Design (AIDD) Picture
Figure 2. World AI-assisted Drug Design (AIDD) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AI-assisted Drug Design (AIDD) Total Market Size (2018-2029) & (USD Million)
Figure 4. World AI-assisted Drug Design (AIDD) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World AI-assisted Drug Design (AIDD) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company AI-assisted Drug Design (AIDD) Revenue (2018-2029) & (USD Million)
Figure 13. AI-assisted Drug Design (AIDD) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 16. World AI-assisted Drug Design (AIDD) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 18. China AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 23. India AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of AI-assisted Drug Design (AIDD) by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI-assisted Drug Design (AIDD) Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI-assisted Drug Design (AIDD) Markets in 2022
Figure 27. United States VS China: AI-assisted Drug Design (AIDD) Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AI-assisted Drug Design (AIDD) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World AI-assisted Drug Design (AIDD) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World AI-assisted Drug Design (AIDD) Market Size Market Share by Type in 2022
Figure 31. Hardware
Figure 32. Software
Figure 33. Service
Figure 34. World AI-assisted Drug Design (AIDD) Market Size Market Share by Type (2018-2029)
Figure 35. World AI-assisted Drug Design (AIDD) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World AI-assisted Drug Design (AIDD) Market Size Market Share by Application in 2022
Figure 37. Early Drug Discovery
Figure 38. Preclinical Phase
Figure 39. Clinical Phase
Figure 40. Regulatory Approval
Figure 41. AI-assisted Drug Design (AIDD) Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
